The PPARG mutation is a loss-of-function mutation, but did not manifest dominant negative activity, which is a feature of the other PPARG variants shown to be associated with partial lipodystrophy and severe insulin resistance [31]. The gene discussed is PPARG; the disease is partial lipodystrophy.